Quantbot Technologies LP Evelo Biosciences, Inc. Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$1.46 - $3.55 $1,314 - $3,195
-900 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.66 - $6.63 $7,182 - $17,901
-2,700 Reduced 75.0%
900 $3,000
Q4 2021

Feb 11, 2022
BUY
$6.07 - $12.0 $21,852 - $43,200
3,600 New
3,600 $21,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email